Axonics Inc (AXNX)
67.09
-0.04
(-0.06%)
USD |
NASDAQ |
May 31, 16:00
67.16
+0.07
(+0.10%)
Pre-Market: 20:00
Axonics SG&A Expense (Annual): 235.32M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 235.32M |
| December 31, 2022 | 196.26M |
| December 31, 2021 | 135.83M |
| December 31, 2020 | 91.68M |
| Date | Value |
|---|---|
| December 31, 2019 | 67.75M |
| December 31, 2018 | 13.09M |
| December 31, 2017 | 5.852M |
| December 31, 2016 | 4.973M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
67.75M
Minimum
2019
235.32M
Maximum
2023
145.37M
Average
135.83M
Median
2021
SG&A Expense (Annual) Benchmarks
| Boston Scientific Corp | 5.19B |
| Cutera Inc | 176.32M |
| Stereotaxis Inc | 26.43M |
| Electromed Inc | 31.60M |
| Myomo Inc | 18.78M |